News
YCBD
0.7790
+7.01%
0.0510
cbdMD Updates Director Equity Awards and Compensation Structure
TipRanks · 2h ago
Weekly Report: what happened at YCBD last week (0406-0410)?
Weekly Report · 2d ago
Weekly Report: what happened at YCBD last week (0330-0403)?
Weekly Report · 04/06 10:17
cbdMD Shareholders Approve Reverse Split and Capital Plans
TipRanks · 04/01 20:38
cbdMD Shareholders Approve Potential Reverse Stock Split Of Up To 1-for-10
Benzinga · 04/01 20:13
cbdMD Introduces Clinical Healthcare Channel
Benzinga · 04/01 12:40
cbdMD Launches Clinical Healthcare Channel to Support First Federal Pathway for Hemp-Derived CBD in Medicare
PR Newswire · 04/01 12:30
Weekly Report: what happened at YCBD last week (0323-0327)?
Weekly Report · 03/30 10:18
Weekly Report: what happened at YCBD last week (0316-0320)?
Weekly Report · 03/23 10:14
Weekly Report: what happened at YCBD last week (0309-0313)?
Weekly Report · 03/16 10:14
Weekly Report: what happened at YCBD last week (0302-0306)?
Weekly Report · 03/09 10:14
Weekly Report: what happened at YCBD last week (0223-0227)?
Weekly Report · 03/02 10:13
Weekly Report: what happened at YCBD last week (0216-0220)?
Weekly Report · 02/23 10:13
Buy Rating Reaffirmed on cbdMD: Strengthening Fundamentals, Strategic Bluebird Acquisition, and Discounted Valuation Support $2.00 Target
TipRanks · 02/19 17:45
Cbdmd Inc. Earnings Call Signals Cautious Recovery
TipRanks · 02/19 00:05
cbdMD Q1 Earnings Report: What Investors Need to Know
Benzinga · 02/17 21:38
cbdMD Q1 EPS $(0.04) Beats $(0.06) Estimate, Sales $5.017M Beat $4.858M Estimate
Benzinga · 02/17 21:38
Press Release: cbdMD Reports Sequential Revenue Growth, Improved Liquidity, and Strong Start to Fiscal 2026
Dow Jones · 02/17 21:10
Press Release: cbdMD Reports Sequential Revenue -2-
Dow Jones · 02/17 21:10
cbdMD Reports Sequential Revenue Growth, Improved Liquidity, and Strong Start to Fiscal 2026
PR Newswire · 02/17 21:10
More
Webull provides a variety of real-time YCBD stock news. You can receive the latest news about Cbdmd Inc through multiple platforms. This information may help you make smarter investment decisions.
About YCBD
cbdMD, Inc. is a consumer wellness company focused on the development, manufacturing, marketing, and sale of supplement brands powered by natural compounds. Its hemp-derived cannabinoids, include full-spectrum cannabidiol (CBD) formulations, hemp-derived Delta-9 THC products and a range of functional products designed to address key wellness needs, such as sleep, recovery, mood, discomfort, mobility, cognitive function, and stress management. It operates a multi-brand portfolio anchored by its flagship cbdMD line, which offers oils, gummies, capsules, soft-gels, topicals, functional formulations, and hemp-derived compliant Delta-9 THC products. Its Paw CBD pet-wellness brand provides tinctures, chews, and topicals for dogs and cats. Its ATRX platform offers non-cannabinoid functional ingredients such as functional mushrooms. Its Herbal Oasis (Oasis) brand is a premium hemp-derived THC-infused social seltzer that blends cannabinoids and nootropic mushrooms.